Diabetes Clinical Trial
Official title:
The Effect of Dopamine on Diabetic Retinopathy
The purpose of this study is to evaluate the use of electroretinogram (ERG) using a novel
handheld system, RETeval, and evaluate contrast sensitivity testing in detecting pre-clinical
retinopathy on a tablet device.
Investigators also seek to assess if a medication called Sinemetâ„¢ CR can improve the
electrical functions of the eye in participants with diabetes mellitus. This study will
include a total of 45 participants; 30 with diabetes mellitus and 15 age-matched non-diabetic
controls. Participants with diabetes mellitus and electroretinogram (ERG) delays will be
randomized to a low or high dose Sinemet CR group.
The purpose of this study is to evaluate the use of electroretinogram (ERG) using a novel
handheld system, RETeval, and evaluate contrast sensitivity testing in detecting pre-clinical
retinopathy on a tablet device.
Investigators also seek to assess if a medication called Sinemetâ„¢ CR can improve the
electrical functions of the eye in participants with diabetes mellitus. This study will
include a total of 45 participants; 30 with diabetes mellitus and 15 age-matched non-diabetic
controls. Participants with diabetes mellitus and electroretinogram (ERG) delays will be
randomized to a low or high dose Sinemetâ„¢ CT group.
Age-matched controls will not receive Sinemet Ct drug treatment.
The study involves four visits over the course of 4 weeks, each visit consisting of 2-3
hours. Visual testing will be performed at 1 day and 2 weeks following treatment. The drug
treatment will be halted and testing repeated again after a 2 week wash-out period.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05594446 -
Morphometric Study of the Legs and Feet of Diabetic Patients in Order to Collect Data Intended to be Used to Measure by Dynamometry the Pressures Exerted by Several Medical Compression Socks at the Level of the Forefoot
|
||
Completed |
NCT03975309 -
DHS MIND Metabolomics
|
||
Completed |
NCT01855399 -
Technologically Enhanced Coaching: A Program to Improve Diabetes Outcomes
|
N/A | |
Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
Recruiting |
NCT04984226 -
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
|
Phase 2 | |
Recruiting |
NCT05007990 -
Caregiving Networks Across Disease Context and the Life Course
|
||
Active, not recruiting |
NCT04420936 -
Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care for Our Program
|
N/A | |
Recruiting |
NCT03549559 -
Imaging Histone Deacetylase in the Heart
|
N/A | |
Completed |
NCT04903496 -
Clinical Characteristics and Disease Burden of Diabetic Patients Based on Tianjin Regional Database
|
||
Completed |
NCT01437592 -
Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT03390179 -
Hyperglycemic Response and Steroid Administration After Surgery (DexGlySurgery)
|
||
Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
Recruiting |
NCT05294822 -
Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes
|
N/A | |
Completed |
NCT04427982 -
Dance and Diabetes/Prediabetes Self-Management
|
N/A | |
Completed |
NCT02356848 -
STEP UP to Avert Amputation in Diabetes
|
N/A | |
Completed |
NCT03292185 -
A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects
|
Phase 1 | |
Active, not recruiting |
NCT05477368 -
Examining the Feasibility of Prolonged Ketone Supplement Drink Consumption in Adults With Type 2 Diabetes
|
N/A | |
Completed |
NCT04496401 -
PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus
|
Phase 4 |